ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Immuno Oncology Insights
Latest Publications
TOTAL DOCUMENTS
36
(FIVE YEARS 36)
H-INDEX
0
(FIVE YEARS 0)
Published By Bioinsights Publishing, Ltd.
2634-5099, 2634-5099
Latest Documents
Most Cited Documents
Contributed Authors
Related Sources
Related Keywords
Latest Documents
Most Cited Documents
Contributed Authors
Related Sources
Related Keywords
Microphysiological systems for immuno-oncology: opportunities and challenges
Immuno Oncology Insights
◽
10.18609/ioi.2021.027
◽
2021
◽
Vol 2
(4)
◽
pp. 203-206
Author(s):
Lucie A Low
Keyword(s):
Microphysiological Systems
Download Full-text
Recent evolution in the bispecific antibody and engineered cytokine fields
Immuno Oncology Insights
◽
10.18609/ioi.2021.026
◽
2021
◽
Vol 2
(4)
◽
pp. 195-201
Author(s):
Raphael Clynes
Keyword(s):
Bispecific Antibody
Download Full-text
Advancement of precision oncology by integration of highly sensitive protein profiling technologies and patient-derived cell models for functional efficacy testing
Immuno Oncology Insights
◽
10.18609/ioi.2021.013
◽
2021
◽
Vol 2
(4)
◽
pp. 171-185
Author(s):
Michael Pawlak
◽
Markus Templin
◽
Christian Schmees
Keyword(s):
Protein Profiling
◽
Precision Oncology
◽
Cell Models
◽
Highly Sensitive
Download Full-text
Enhancing preclinical predictivity: what is going wrong between preclinical in vitro/in vivo and clinical in vivo settings?
Immuno Oncology Insights
◽
10.18609/ioi.2021.030
◽
2021
◽
Vol 2
(4)
◽
pp. 225-227
Author(s):
Christian Schmees
Download Full-text
Translational R&D insights for the allogeneic CAR T cell therapy field and beyond
Immuno Oncology Insights
◽
10.18609/ioi.2021.025
◽
2021
◽
Vol 2
(4)
◽
pp. 187-193
Author(s):
Barbra Sasu
Keyword(s):
T Cell
◽
Cell Therapy
◽
T Cell Therapy
◽
Car T Cell
◽
Car T Cell Therapy
◽
Car T
◽
Therapy Field
Download Full-text
T cell characterization in 3D cell models using advanced flow cytometry
Immuno Oncology Insights
◽
10.18609/ioi.2021.028
◽
2021
◽
Vol 2
(4)
◽
pp. 207-207
Keyword(s):
Flow Cytometry
◽
T Cell
◽
Cell Models
◽
Cell Characterization
Download Full-text
Enhancing preclinical predictivity in I-O: what is going wrong between preclinical in vitro/in vivo and clinical settings?
Immuno Oncology Insights
◽
10.18609/ioi.2021.029
◽
2021
◽
Vol 2
(4)
◽
pp. 209-224
Author(s):
Peter Ellmark
◽
David Gilham
◽
Martin Steegmaier
◽
Mihriban Tuna
◽
Markus Zettl
Keyword(s):
Clinical Settings
Download Full-text
Hunting for better biomarkers of response: where is real progress being made in understanding why patients do and don’t respond to I-O therapeutics?
Immuno Oncology Insights
◽
10.18609/ioi.2021.021
◽
2021
◽
Vol 2
(3)
◽
pp. 133-102
Author(s):
Dr Adil Daud
◽
Steven Fling
◽
John Rossi
◽
Dr Majid Ghoddusi
Keyword(s):
Real Progress
◽
Made In
Download Full-text
Leveraging the advantages of liquid biopsy for predictive and prognostic biomarkers in R&D
Immuno Oncology Insights
◽
10.18609/ioi.2021.023
◽
2021
◽
Vol 2
(3)
◽
pp. 147-149
Author(s):
Chamindie Punyadeera
Keyword(s):
Liquid Biopsy
◽
Prognostic Biomarkers
Download Full-text
Reflecting on Merck’s I-O biomarker development journey
Immuno Oncology Insights
◽
10.18609/ioi.2021.008
◽
2021
◽
Vol 2
(3)
◽
pp. 115-121
Author(s):
Eric H Rubin, MD Eric H Rubin, MD
Download Full-text
Load More ...
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close